We are live on
!
Find out more
EAM
Empery Asset Management Portfolio holdings
AUM
$86.5M
This Fund
S&P 500
This Quarter
Est. Return
-3.78%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.8M
AUM Growth
-$1.66M
(-9%)
Cap. Flow
+$4.09M
Cap. Flow
% of AUM
24.34%
Top 10 Holdings %
Top 10 Hldgs %
63.43%
Holding
94
New
19
Increased
–
Reduced
7
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBX
Unity Biotechnology
UBX
|
+$2.78M |
| 2 |
Greenwave Technology Solutions
GWAV
|
+$1.97M |
| 3 |
DFTX
Definium Therapeutics
DFTX
|
+$1.8M |
| 4 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
+$746K |
| 5 |
MDNA
Medicenna Therapeutics Corp. Common Shares
MDNA
|
+$665K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MMAT
Meta Materials Inc. Common Stock
MMAT
|
+$4.5M |
| 2 |
SELLAS Life Sciences
SLS
|
+$1.71M |
| 3 |
APLT
Applied Therapeutics
APLT
|
+$640K |
| 4 |
SVRE
SaverOne 2014 Ltd
SVRE
|
+$118K |
| 5 |
Surrozen
SRZN
|
+$118K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.35% |
| 2 | Healthcare | 42.69% |
| 3 | Technology | 7.19% |
| 4 | Industrials | 6.37% |
| 5 | Communication Services | 0.37% |
Similar funds
BCM
TI
LCM
AA
YAG
CL
TWM
BI
Empery Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Empery Asset Management held 94 positions worth $16.8M, down 9% from $18.5M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Empery Asset Management deployed $4.09M of net new capital in Q3 2022, opening 19 new positions. Its largest new stake was Unity Biotechnology: 441,165 shares worth $1.74M.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, down from 49% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was SELLAS Life Sciences, an estimated $1.71M trimmed.
- Empery Asset Management's largest Q3 2022 buy was Unity Biotechnology: 441,165 shares worth $1.74M.
- Empery Asset Management's biggest Q3 2022 reduction was SELLAS Life Sciences, cutting an estimated $1.71M.
- Empery Asset Management fully exited Meta Materials Inc. Common Stock in Q3 2022, selling an estimated $4.5M.
- Empery Asset Management's ten largest holdings make up 63% of its $16.8M portfolio in Q3 2022.
- Empery Asset Management opened 19 new positions and closed 6 in Q3 2022.
- Empery Asset Management's portfolio value fell 9% quarter-over-quarter to $16.8M.
Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.